Psychedelics Company Silo Wellness Announces Financing Commitment of CAD$5,950,000 in Convertible Debentures Psychedelics Investing
Awakn Life Sciences Provides Shareholder Update on Three Operational Ketamine-Assisted Therapy Clinics in the UK and Norway Psychedelics Investing
NeonMind Announces Plan to Launch 10 Clinics for Innovative Treatments as Mental Health Crisis Grows Psychedelics Investing
Nirvana Life Sciences Inc. Contracts Stratus Designs for Mechanical Service to Laboratory Psychedelics Investing
Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research Pharmaceutical Investing
Seelos Therapeutics Announces Amendment of SLS-002 Agreement to Repurchase the Remaining Royalties Payable to Phoenixus AG for SLS-002 , All Future Success and Commercial Based Milestones and the Change of Control Fee Psychedelics Investing
